Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves expansion of cancer drug use
Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.
Read the full post on Becker's Hospital Review - Healthcare News